Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Paediatric solid tumours

Medulloblastoma Group 3/4 - Paediatric (M147) and other disease entities

  • Gain or amplification of MYCN FISH (M147.4)
  • Gain or amplification of MYC FISH (M147.5)
  • i(17q) / del(17p) FISH can also be performed if considered clinically relevant. This test may not be included in the TD for the disease entity, in which case the test will be invoiced separately. Please contact us to discuss further.

It may be clinically relevant to undertake these studies when there is a differential diagnosis of another tumour type and the results will aid patient management.

Midline Carcinoma - Paediatric (M151)

NUTM1 rearrangement FISH (M151.1); undertaken using a NUTM1 breakapart probe only, therefore partner gene is not identifiable

Oligodendroglioma - Paediatric (M156) and other disease entities

1p & 19q codeletion FISH (M156.5)

It may be clinically relevant to undertake these studies when there is a differential diagnosis of another tumour type and the results will aid patient management.